Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 17290056

Dexrazoxane-associated risk for acute myeloid leukemia/myelodysplastic syndrome and other secondary malignancies in pediatric Hodgkin's disease.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2007 Feb 10
First author
Tebbi CK

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2007 Jul 20;25(21):3179; author reply 3180. doi: 10.1200/JCO.2007.11.8778.
    note
    Source null
    related pmid
    17634500
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2007 Oct 10;25(29):4689-90; author reply 4690-1. doi: 10.1200/JCO.2007.12.6888.
    note
    Source null
    related pmid
    17925567
    relationship
    Comment in

Authors and identifiers

  1. name
    Tebbi CK
    type
    Author
  2. name
    London WB
    type
    Author
  3. name
    Friedman D
    type
    Author
  4. name
    Villaluna D
    type
    Author
  5. name
    De Alarcon PA
    type
    Author
  6. name
    Constine LS
    type
    Author
  7. name
    Mendenhall NP
    type
    Author
  8. name
    Sposto R
    type
    Author
  9. name
    Chauvenet A
    type
    Author
  10. name
    Schwartz CL
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Tebbi CK
    type
    Author
  2. name
    London WB
    type
    Author
  3. name
    Friedman D
    type
    Author
  4. name
    Villaluna D
    type
    Author
  5. name
    De Alarcon PA
    type
    Author
  6. name
    Constine LS
    type
    Author
  7. name
    Mendenhall NP
    type
    Author
  8. name
    Sposto R
    type
    Author
  9. name
    Chauvenet A
    type
    Author
  10. name
    Schwartz CL
    type
    Author
bibliography ids
  1. nci-bib-7e3bbd24808c55ed10a10350
book metadata
content sha256
98db7fc1d7a259da6706eb75c6ba8c0f3c198bfa6d853820c5aa8490e53bf002
document type
citation
dois
  1. 10.1200/JCO.2005.02.3879
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:17290056
immutable id
pubmed:17290056@98db7fc1d7a259da6706eb75c6ba8c0f3c198bfa6d853820c5aa8490e53bf002
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
5
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
493-500
volume
25
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2007 Jul 20;25(21):3179; author reply 3180. doi: 10.1200/JCO.2007.11.8778.
    note
    Source null
    related pmid
    17634500
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2007 Oct 10;25(29):4689-90; author reply 4690-1. doi: 10.1200/JCO.2007.12.6888.
    note
    Source null
    related pmid
    17925567
    relationship
    Comment in
outcomes validated
false
pmid
17290056
provenance
batch id
e687ecc838c318f9ec65
provider
NCBI PubMed ESummary
record sha256
aeae3250cda558f64331d440990c8dc75af65b8c03e48cd5b50906de0bd0d1e3
response sha256
57c28819ed5384f58bd55b57a106357c87d58ddac21f26fe526ca7520d9f61c6
retrieved at
2026-09-09T23:46:11.674833+00:00
publication date
display
2007 Feb 10
precision
day
year
2007
publication types
  1. Journal Article
  2. Multicenter Study
  3. Randomized Controlled Trial
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/17290056/
title
Dexrazoxane-associated risk for acute myeloid leukemia/myelodysplastic syndrome and other secondary malignancies in pediatric Hodgkin's disease.

Preserved source evidence · Not medical advice